Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1936 of 6351
-
Could a gene test pick the right blood pressure pill for black patients?
Disease control OngoingLysine specific demethylase-1 (LSD1) is an epigenetic regulator of gene transcription involved in the pathophysiology of elevated blood pressure and likely renal damage in Blacks. This project investigates whether a genetically driven anti-hypertensive approach proves superior in…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Stem cell shots take on long COVID: hope for millions?
Symptom relief CompletedThis study will enroll up to 80 subjects with Chronic Post COVID-19 Syndrome. Subjects will receive four intravenous injections of either allogeneic HB-adMSC's or a placebo over 10 weeks with two follow-up visits and an end of study visit at week 26.
Phase 2 • Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail takes on hard-to-treat lymphomas
Disease control OngoingThis is an international, multicenter, multi-arm, phase Ib, model-based dose-escalation study. The primary objectives of the study in each arm is to determine the maximum tolerated dose (MTD), recommended phase 2 dose (RP2D), dose limiting toxicities (DLTs) and to evaluate the cl…
Phase 1 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a new basket catheter clear large bile duct stones better?
Disease control Recruiting nowInvestigators will perform randomized trial of the removal ability with Vortic Catch V basket catheter versus ordinary basket catheter for bile duct stones (≧ 10 mm).
Sponsor: Akira Horiuchi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Cancer pill may boost ablation success in aggressive liver tumors
Disease control OngoingPercutaneous ablation (PA) is the only non-surgical curative treatment of hepatocellular carcinoma (HCC). Due to its excellent tolerance, particularly in patients with portal hypertension or bearing comorbidities, it now represents in France nearly 70% of the first-line curative …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New shot could help raise platelet levels in chronic blood disorder
Disease control Recruiting nowThis is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with primary immune thrombocytopenia (ITP). This study will focus on participants with persistent (\>3 months and ≤12 months), or chronic (\…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug trial hopes to shrink Hard-to-Treat tumors
Disease control OngoingThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-2-307-ADC in patients with advanced cancer
Phase 1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can we predict who dies from blood clots? a 100,000-Patient study searches for clues
Knowledge-focused CompletedStudy population and characteristics This retrospective cohort study initially screened 105,168 consecutive hospitalized patients at Shihezi People's Hospital from February 2022 to June 2025. Acute symptomatic venous thromboembolism (VTE) was defined as newly diagnosed deep vein …
Sponsor: China International Neuroscience Institution • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New targeted drug shows promise for rare genetic cancer
Disease control OngoingThe primary objective of Parts 1 and 2 of this study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D) of Anvumetostat alone and in combination with docetaxel in adult participants with metastatic or loca…
Phase 1/2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for rare dementia: experimental drug DNL593 enters human trials
Disease control OngoingThis is a Phase 1/2, multicenter, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple doses of DNL593 in two parts followed by an optional open-label extension (OLE) perio…
Phase 1/2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
EMDR therapy tested for addiction and trauma – could it reduce relapse?
Symptom relief CompletedSubstance Use Disorders (SUD) are often comorbid with psychological trauma, however, the complex interaction between the two is not yet fully understood. Most addiction-specialized professionals do not engage in exploring past traumatic experiences of the patients due to personal…
Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Jun 26, 2026 18:10 UTC
-
Could a growth hormone help people with End-Stage liver disease?
Disease control CompletedGlobally, cirrhosis and liver cancer carries a huge burden and accounts for about 3.5% (2 million) of all deaths every year. Once decompensated, i.e. development of ascites, variceal bleed, encephalopathy, and jaundice, the life expectancy is markedly reduced to a median of two y…
Phase 2/3 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New online 'Behavioral Vaccine' aims to stop teen depression before it starts
Prevention OngoingPrevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "b…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Spinal injection may shield brain from lymphoma spread
Prevention CompletedThis is a prospective, single-arm clinical study to evaluate the efficacy and safety of intrathecal thiotepa for the prevention of central nervous system (CNS) involvement in patients with high-aggressive B-cell lymphoma. A total of 32 subjects will be enrolled, and the study is…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Could a flu drug help stroke patients recover?
Disease control Recruiting nowThe investigators aim to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial (RCT). Patients will be randomized post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine arm. Patients will be on stud…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Which graft fuses better after neck surgery? a Head-to-Head test
Disease control CompletedThe cervical spine is the most mobile portion of the spine and is more prone to degenerative spine changes like cervical disc herniation, cervical spine stenosis, ossified posterior longitudinal ligament and osteophyte formation. Cervical spondylosis describes a variety of progre…
Sponsor: Services Hospital, Lahore • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can pulling an all-nighter reveal how depression hijacks sleep and mood?
Knowledge-focused CompletedThis study will investigate how sleep and mood are related in patients with depression and in healthy controls. It will use MRI-based measures of brain function to determine how neural systems are modulated by sleep and sleep deprivation, and its links to mood in depression.
Sponsor: Boston University Charles River Campus • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Promising epilepsy drug trial halted early – what we know
Disease control Stopped earlyThe objective of this study is to assess the efficacy, safety, and pharmacokinetics of NBI-921352 as adjunctive therapy for seizures in subjects with SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE).
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a sleep hormone boost IVF success?
Symptom relief CompletedMelatonin is a potent antioxidant, has been proposed to improve ovarian response and oocyte quality in assisted reproductive technologies (ART). This study evaluated the effects of melatonin supplementation on follicular fluid melatonin levels, hormonal profiles, and reproductive…
Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Your phone could detect Alzheimer's before you know it
Knowledge-focused OngoingAlzheimer's disease (AD) clinically characterized by the cognitive impairment and lowering of various functional abilities lead to staggering costs and suffering, which are particularly related to the social impacts of caring for increasingly disabled individuals. Some of these c…
Sponsor: Altoida • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC